Global collagen filler market is estimated to be valued at US$ 486 million in 2023, and is expected to exhibit a CAGR of 7.4% during the forecast period (2023-2030).
Figure 1. Global Collagen Filler Market Share (%), By Product Type, 2023
Based on Region, the global collagen filler market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Among these, North America is expected to dominate the market over the forecast period due to increasing launch of newer products in this region.
Among all segmentation, the product type segment has the highest potential due to increasing launch by the key market players. For instance, on April 20, 2021, Lonza, a Switzerland-based multinational manufacturing company for the pharmaceutical, biotechnology, and nutrition sectors, announced the expansion of UC-II undenatured collagen ingredient line. It is made with organic collagen and non-GMO project verified. Non-GMO means a product was produced without genetic engineering.
Global Collagen Filler Market- Cross Sectional Analysis
Among application, the face rejuvenation segment is dominant during the forecast period in Europe region, due to increasing cosmetic surgeries. For instance, according to the British Association of Aesthetic Plastic Surgeons, 2022, 31,057 cosmetic procedures were performed in 2022, indicating 102% increase from 2021.
Global Collagen Filler Market: Key Trends
Collaborations between key market players
Different medical aesthetic companies are adopting strategies such as collaborations, and agreements, and this is expected to drive the market growth within forecast period. For instance, on May 9, 2023, Evolus, a U.S.-based medical aesthetic company, collaborated with Symatese, a France- based surgical products company, and announced its expansion into U.S. Dermal Filler Market with Evolysse, a First-Generation Cold Technology hyaluronic acid.
Research and development by key market players
Increasing research and development activities by market players is expected to drive the global collagen filler market growth over forecast period.According to the data published on December 3, 2021, by clinical trial site of U.S. National Library of Medicine, clinical trials were carried out by Dr. Korman Laboratories Ltd., an Israel- based aesthetic medicine company, for assessing Safety and Performance of Depolymerized kraft lignin Crosslinked Sodium Hyaluronate 23 Dermal Filler for improvement of nasolabial fold Appearance, started in 2021.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients